Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeru Matsuda

Showing results (161-170 of 233) with videos related to

Pageof 24
Sort By:
Surgical Endoscopy|May 20, 2024
The number of resected lymph nodes from the upper mediastinal area predicts long-term outcomes of esophageal squamous cell carcinoma after minimally invasive esophagectomyYasufumi Koterazawa, Hironobu Goto, Hiroshi Saiga, et al.
Anticancer Research|December 3, 2024
Prognostic Impact of Squamous Cell Carcinoma Antigen During Neoadjuvant Chemotherapy for Patients With Esophageal Squamous Cell Carcinoma Treated With Minimally Invasive EsophagectomyRikuya Torigoe, Taro Oshikiri, Hironobu Goto, et al.
World Journal of Surgery|November 23, 2024
Omission of lymph node dissection along the recurrent laryngeal nerve for lower thoracic esophageal squamous cell carcinoma with short esophageal invasionYasufumi Koterazawa, Hironobu Goto, Hiroshi Saiga, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 31, 2022
Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classificationTaro Oshikiri, Hironobu Goto, Takashi Kato, et al.
Annals of Gastroenterological Surgery|January 31, 2019
Recent advances of neoadjuvant chemoradiotherapy in rectal cancer: Future treatment perspectivesKimihiro Yamashita, Takeru Matsuda, Hiroshi Hasegawa, et al.
Annals of Surgical Oncology|November 22, 2021
Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell CarcinomaTomoki Abe, Taro Oshikiri, Hironobu Goto, et al.
Annals of Surgical Oncology|May 26, 2022
ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell CarcinomaTomoki Abe, Taro Oshikiri, Hironobu Goto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[A Case of Gastric Carcinoma with Peritoneal Dissemination Treated with Curative Resection Following Trastuzumab plus Capecitabine plus Cisplatin Combined Therapy]Yusuke Matsuda, Satoshi Suzuki, Ritsuko Maehara, et al.
Surgery Today|May 30, 2026
Chronological age does not predict poor outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a retrospective studyYasunori Otowa, Takeru Matsuda, Masayuki Ando, et al.
World Journal of Surgery|April 9, 2026
Biological Age Reflects Physical Condition and Predicts Postoperative Complications Beyond Chronological Age in Patients With Esophageal Squamous Cell Carcinoma Undergoing Minimally Invasive EsophagectomyYasufumi Koterazawa, Hironobu Goto, Tomoaki Aoki, et al.
Pageof 24

Showing results (161-170 of 233) with videos related to

Sort By:
Pageof 24
Surgical Endoscopy|May 20, 2024
The number of resected lymph nodes from the upper mediastinal area predicts long-term outcomes of esophageal squamous cell carcinoma after minimally invasive esophagectomyYasufumi Koterazawa, Hironobu Goto, Hiroshi Saiga, et al.
Anticancer Research|December 3, 2024
Prognostic Impact of Squamous Cell Carcinoma Antigen During Neoadjuvant Chemotherapy for Patients With Esophageal Squamous Cell Carcinoma Treated With Minimally Invasive EsophagectomyRikuya Torigoe, Taro Oshikiri, Hironobu Goto, et al.
World Journal of Surgery|November 23, 2024
Omission of lymph node dissection along the recurrent laryngeal nerve for lower thoracic esophageal squamous cell carcinoma with short esophageal invasionYasufumi Koterazawa, Hironobu Goto, Hiroshi Saiga, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 31, 2022
Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classificationTaro Oshikiri, Hironobu Goto, Takashi Kato, et al.
Annals of Gastroenterological Surgery|January 31, 2019
Recent advances of neoadjuvant chemoradiotherapy in rectal cancer: Future treatment perspectivesKimihiro Yamashita, Takeru Matsuda, Hiroshi Hasegawa, et al.
Annals of Surgical Oncology|November 22, 2021
Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell CarcinomaTomoki Abe, Taro Oshikiri, Hironobu Goto, et al.
Annals of Surgical Oncology|May 26, 2022
ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell CarcinomaTomoki Abe, Taro Oshikiri, Hironobu Goto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[A Case of Gastric Carcinoma with Peritoneal Dissemination Treated with Curative Resection Following Trastuzumab plus Capecitabine plus Cisplatin Combined Therapy]Yusuke Matsuda, Satoshi Suzuki, Ritsuko Maehara, et al.
Surgery Today|May 30, 2026
Chronological age does not predict poor outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a retrospective studyYasunori Otowa, Takeru Matsuda, Masayuki Ando, et al.
World Journal of Surgery|April 9, 2026
Biological Age Reflects Physical Condition and Predicts Postoperative Complications Beyond Chronological Age in Patients With Esophageal Squamous Cell Carcinoma Undergoing Minimally Invasive EsophagectomyYasufumi Koterazawa, Hironobu Goto, Tomoaki Aoki, et al.
Pageof 24